Cargando…
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
BACKGROUND: Ovarian cancer (OC), a kind of gynecological cancer, is characterized by high mortality rate, with microRNAs (miRNAs) playing essential roles in it. However, the clinical significance of miRNAs and their molecular mechanisms in OC are mostly unknown. METHODS: miR-149-3p expression was pr...
Autores principales: | Wang, Jin, Liu, Lingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605569/ https://www.ncbi.nlm.nih.gov/pubmed/34798882 http://dx.doi.org/10.1186/s13048-021-00919-5 |
Ejemplares similares
-
miR-122 promotes diabetic retinopathy through targeting TIMP3
por: Wang, Mingliang, et al.
Publicado: (2020) -
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
por: Ke, Yang, et al.
Publicado: (2013) -
MiR‐149 sensitizes esophageal cancer cell lines to cisplatin by targeting DNA polymerase β
por: Wang, Yuanyuan, et al.
Publicado: (2018) -
miR-149-5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway
por: Xu, Manman, et al.
Publicado: (2018) -
miR-149 in Human Cancer: A Systemic Review
por: He, Yunjie, et al.
Publicado: (2018)